Bios_Illustration_B_RGB_large.jpg

CODE THE BODY CAN RUN

Creating the programming language for lifelong health

BIOS IT4 DATASET

Visualisation by Andreas Nicolas Fischer

BIOS has launched a flagship programme to realise a neural-cardiac therapy in partnership with the top pharma R&D, academic and technology organisations in the world.

AUTONOMIC

THERAPY INITIATIVE

Panel_1-BG.jpg
 
 
Panel_2_BG.png

CARDIAC DISEASE IS OUR BIGGEST HEALTH CRISIS WITH FEW EFFECTIVE DRUGS

Cardiovascular diseases are responsible for a third of all deaths globally.

However, new cardiovascular disease therapies are very rare due to the high cost and long timescale of trials and the 10,000 to 1 failure rate of new pharmaceutical compounds.

OUR BEACHHEAD WILL BE

TO SURPASS THE BETA BLOCKER FOR CARDIAC DISEASE

By understanding and correcting signals in real time, we can treat chronic cardiac illnesses in an effective, automated and personalized way.

Neural interfaces can be used to form a direct connection with the neurons around the heart and other organs, which offers a whole new class of treatments for cardiovascular disease.

Panel_3_BG.jpg
Panel_4_BG.jpg

WHEN WE CAN CONTROL OUR NEURAL SIGNALS WE CAN PREVENT THE DETERIORATION IN OUR HEALTH

ECG

RESPIRATORY PRESSURE

BLOOD GLUCOSE

 
lines_bg.jpg

THE AUTONOMIC THERAPY INITIATIVE IS POWERED BY DIGITAL NEURAL BIOMARKERS

BIOS uses neural interfaces & AI to discover the language of the nervous system - a code known as digital neural biomarkers

The Autonomic Therapy Initiative (ATI) leverages these unique neural biomarkers to offer precision unseen before in healthcare - giving personalised, real-time treatment recommendations, shaping the design of new therapies and even replacing current drugs with computer generated neural signals

Panel_5_BG.jpg

LEARN MORE ABOUT OUR TECHNOLOGY

ATI LEADERSHIP

EMIL HEWAGE

BIOS CEO & Founder

OLIVER ARMITAGE

BIOS CSO & Founder

PROF. JOANNE HACKETT

BIOS Board Chair

 

ATI ADVISORY PANEL

PROF. TIM DENISON

Royal Academy of Engineering Chair in BioEngineering at the University of Oxford

(Advisory Panel Chair)

PROF. DAVID PATERSON

Head of Dept of Physiology, Anatomy & Genetics at the University of Oxford

MONA FLORES MD

Global Head of Medical AI

at Nvidia

DR. CEM BAYDAR

Head of Portfolio Strategy & Consulting Services at IQVIA

team_panel_BG.jpg

Our vision is a future where we have control over our bodies and lives, enabling radically improved, seamlessly experienced healthcare.

DIGITAL NEURAL
BIOMARKERS
THOUSANDS OF POSSIBLE
TREATMENTS
 

Interested in collaborating or learning more about the ATI programme?

Contact us at info@BIOS.health

or fill in the form opposite.

Interested in working with us? 

Take a look at our current vacancies or contact us at careers@BIOS.health

Privacy Policy - Terms and Conditions - Financial Conflicts of Interest Policy

 

©2020 BIOS